Cara Therapeutics Statistics
Total Valuation
CARA has a market cap or net worth of $24.33 million. The enterprise value is $30.88 million.
| Market Cap | 24.33M |
| Enterprise Value | 30.88M |
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CARA has 1.52 million shares outstanding. The number of shares has increased by 1.12% in one year.
| Current Share Class | 1.52M |
| Shares Outstanding | 1.52M |
| Shares Change (YoY) | +1.12% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 3.62% |
| Owned by Institutions (%) | 98.30% |
| Float | 3.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.40 |
| Forward PS | 6.63 |
| PB Ratio | -5.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.03
| Current Ratio | 11.03 |
| Quick Ratio | 10.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.58 |
Financial Efficiency
Return on equity (ROE) is -270.01% and return on invested capital (ROIC) is -49.77%.
| Return on Equity (ROE) | -270.01% |
| Return on Assets (ROA) | -41.09% |
| Return on Invested Capital (ROIC) | -49.77% |
| Return on Capital Employed (ROCE) | -139.96% |
| Revenue Per Employee | $713,700 |
| Profits Per Employee | -$7.09M |
| Employee Count | 10 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 19.56 |
Taxes
| Income Tax | -398,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.66% in the last 52 weeks. The beta is 0.41, so CARA's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -80.66% |
| 50-Day Moving Average | 15.19 |
| 200-Day Moving Average | 12.63 |
| Relative Strength Index (RSI) | 55.82 |
| Average Volume (20 Days) | 10,169 |
Short Selling Information
The latest short interest is 66,472, so 4.36% of the outstanding shares have been sold short.
| Short Interest | 66,472 |
| Short Previous Month | 73,840 |
| Short % of Shares Out | 4.36% |
| Short % of Float | 1.70% |
| Short Ratio (days to cover) | 5.69 |
Income Statement
In the last 12 months, CARA had revenue of $7.14 million and -$70.87 million in losses. Loss per share was -$46.60.
| Revenue | 7.14M |
| Gross Profit | -29.25M |
| Operating Income | -55.78M |
| Pretax Income | -122.54M |
| Net Income | -70.87M |
| EBITDA | -55.59M |
| EBIT | -55.78M |
| Loss Per Share | -$46.60 |
Balance Sheet
The company has $37.90 million in cash and $44.45 million in debt, giving a net cash position of -$6.55 million or -$4.29 per share.
| Cash & Cash Equivalents | 37.90M |
| Total Debt | 44.45M |
| Net Cash | -6.55M |
| Net Cash Per Share | -$4.29 |
| Equity (Book Value) | -4.59M |
| Book Value Per Share | -3.01 |
| Working Capital | 39.86M |
Cash Flow
In the last 12 months, operating cash flow was -$60.92 million and capital expenditures -$1.05 million, giving a free cash flow of -$61.96 million.
| Operating Cash Flow | -60.92M |
| Capital Expenditures | -1.05M |
| Free Cash Flow | -61.96M |
| FCF Per Share | -$40.64 |
Margins
| Gross Margin | n/a |
| Operating Margin | -781.57% |
| Pretax Margin | -998.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CARA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.12% |
| Shareholder Yield | -1.12% |
| Earnings Yield | -291.26% |
| FCF Yield | -254.66% |
Analyst Forecast
The average price target for CARA is $12.00, which is -24.81% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.00 |
| Price Target Difference | -24.81% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 31, 2024. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Dec 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
CARA has an Altman Z-Score of -26.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.74 |
| Piotroski F-Score | 3 |